Stay updated on Epacadostat Combo with Pembrolizumab in Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Epacadostat Combo with Pembrolizumab in Sarcoma Clinical Trial page.

Latest updates to the Epacadostat Combo with Pembrolizumab in Sarcoma Clinical Trial page
- Check5 days agoChange DetectedAdded a Locations section with New York as a study site. Removed the separate New York Locations listing and the HHS Vulnerability Disclosure footer; updated the page to revision v3.3.3.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe page footer now shows Revision: v3.3.2, replacing v3.2.0. This is a minor version update with no changes to the study details or other user-facing content.SummaryDifference0.1%

- Check41 days agoChange DetectedNotice about government funding and NIH operating status banner removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check55 days agoChange DetectedNo significant updates to the study details were observed; the changes appear limited to minor formatting or date-related adjustments.SummaryDifference0.5%

- Check84 days agoChange DetectedUpdated the page to v3.2.0 with a prominent notice about potential data/tansaction delays due to funding gaps and where to check operating status; previous v3.1.0 reference removed.SummaryDifference3%

- Check91 days agoChange DetectedThe page updates its version from v3.0.2 to v3.1.0, indicating a new release without other substantive content changes.SummaryDifference0.1%

Stay in the know with updates to Epacadostat Combo with Pembrolizumab in Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat Combo with Pembrolizumab in Sarcoma Clinical Trial page.